Sei Investments CO Madrigal Pharmaceuticals, Inc. Transaction History

Sei Investments CO

$75.3 Billion
Q4 2024

A detailed history of Sei Investments CO transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Sei Investments CO holds 8,229 shares of MDGL stock, worth $2.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,229

Previous 9,252 11.06%

Holding current value

$2.8 Million

Previous $1.96 Million 29.34%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$202.45 - $354.85 $207,106 - $363,011	-1,023 Reduced 11.06%	8,229 $2.54 Million
Q3 2024 Nov 12, 2024	SELL	$212.22 - $292.96 $116,084 - $160,249	-547 Reduced 5.58%	9,252 $1.96 Million
Q2 2024 Aug 13, 2024	SELL	$193.33 - $291.99 $126,824 - $191,545	-656 Reduced 6.27%	9,799 $2.75 Million
Q1 2024 May 07, 2024	SELL	$171.37 - $283.23 $79,344 - $131,135	-463 Reduced 4.24%	10,455 $2.79 Million
Q4 2023 Feb 14, 2024	BUY	$120.4 - $237.13 $99,932 - $196,817	830 Added 8.23%	10,918 $2.53 Million
Q3 2023 Nov 14, 2023	SELL	$146.04 - $225.78 $463,823 - $717,077	-3,176 Reduced 23.94%	10,088 $1.47 Million
Q2 2023 Aug 11, 2023	BUY	$203.88 - $312.0 $1.06 Million - $1.63 Million	5,221 Added 64.91%	13,264 $3.06 Million
Q1 2023 May 12, 2023	BUY	$231.06 - $307.08 $642,115 - $853,375	2,779 Added 52.79%	8,043 $1.95 Million
Q4 2022 Feb 10, 2023	BUY	$58.39 - $296.54 $307,364 - $1.56 Million	5,264 New	5,264 $1.53 Million
Q2 2022 Aug 15, 2022	SELL	$58.04 - $100.2 $163,846 - $282,864	-2,823 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$55.89 - $101.89 $4,471 - $8,151	80 Added 2.92%	2,823 $277,000
Q4 2021 Feb 14, 2022	SELL	$72.34 - $95.09 $16,927 - $22,251	-234 Reduced 7.86%	2,743 $232,000
Q2 2021 Aug 06, 2021	BUY	$97.2 - $137.59 $289,364 - $409,605	2,977 New	2,977 $290,000
Q1 2019 May 15, 2019	SELL	$103.48 - $143.84 $48,118 - $66,885	-465 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$207.3 - $300.31 $1.1 Million - $1.59 Million	-5,291 Reduced 91.92%	465 $100,000
Q2 2018 Aug 03, 2018	BUY	$101.55 - $313.9 $584,521 - $1.81 Million	5,756 New	5,756 $1.61 Million

Others Institutions Holding MDGL

# of Institutions

308

Shares Held

22.4M

Call Options Held

639K

Put Options Held

641K

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.82B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Madrigal Pharmaceuticals, Inc. Transaction History